chrisvoncsefalvay/vaers-outcomes huggingface dataset:
There is a lot of foods I can't eat anymore because they taste and smell bad; There is a lot of foods I can't eat anymore because they taste and smell bad; This is a spontaneous report received from contactable reporter(s) (Other HCP and Consumer or other non HCP). The reporter is the patient.  A 38 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 30Jul2021 (Lot number: EW0198) as dose 1, single and administered in arm right, administration date Aug2021 (Lot number: EW0183) as dose 2, single for covid-19 immunisation. Relevant medical history included: "COVID-19", start date: May2021 (unspecified if ongoing), notes: I had COVID-19; "High blood pressure" (unspecified if ongoing); "Obesity" (unspecified if ongoing). Concomitant medication(s) included: DICYCLOMINE. The following information was reported: TASTE DISORDER (non-serious), PAROSMIA (non-serious) all with onset 21Aug2021, outcome "not recovered" and all described as "There is a lot of foods I can't eat anymore because they taste and smell bad". Relevant laboratory tests and procedures are available in the appropriate section, which included SARS-CoV-1 test, results: positive ( I had covid-19) on an unspecified date in May2021. Therapeutic measures were not taken as a result of taste disorder, parosmia.  Additional information: Facility where the most recent COVID-19 vaccine was administered: Doctor's office/urgent care. Patient mentioned that she lost taste and smell after she had COVID-19 IN May2021, she mentioned that It was coming back by the time I got the vaccine. But after the second vaccine it got worse again. Patient had not taken any other vaccines within 4 weeks prior to the COVID vaccine. patient mentioned that she is unable to eat meat and mentioned as "No matter what kind it is. They all smell they same. This terrible smell that is hard to describe". Since vaccine patient had not been tested for covid-19.   Follow-up attempts are completed. No further information is expected.
Site: Pain at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Medium, Systemic: Flushed / Sweating-Medium
Patient was a 12 year old female with a weight of 94 lbs who came into the clinic with her father for her second dose of the Pfizer vaccine. During the interview, she stated that she did not have any adverse effects with her first dose. At 2:45 pm, after administering her second dose of 0.3 ml of Pfizer vaccine, I witnessed her having trouble standing up and assisted her back down into the seat. She vomited, was pale and diaphoretic. We elevated her legs up onto a bench and began fluid resuscitation. Her first BP was 71/55 and respiratory rate was unlabored. At 3:00 pm her second vitals were BP: 82/69, RR: unlabored, SPO2: 98, HR: 80.  At 3:07 pm her third vitals were BP:83/64, RR: unlabored, SPO2: 99, HR:74. We changed her position from legs elevated to 90 degree angle. Fluids and crackers were still being administered. At 3:16 pm her fourth vitals were BP: 94/76, RR; unlabored, SPO2: 85, HR 67.  At 3:30 pm her final vital signs were BP: 96/74, RR: 14, SPO2: 99, HR: 70. The patient was given a total of 60 oz of fluid and 1 pack of crackers.  I reassessed that the patient's hemodynamic status improved and her skin was warm and dry. The patient was alert and oriented throughout the process. Her father stated that she no longer looked pale. She was brought to the observation room for another 15 minutes and her father was informed about the progression of her condition. He was informed to refer to her pediatrician if there were any other adverse effects related to the vaccine or changes in her condition.
Patient is a teacher.  Patient reached out to her school nurse, stating her husband said she looked "flushed".  She checked her BP at that time and it was high.  Attempted to reach out to patient, left message, have not received a call back.
pinkish area on arm BELOW injection site and to the left if another person is looking at the arm   if I am looking it is below and to the right  area is about 3 inches by 2 1/2 inches in area
unconscious 3 times only for a second, kind of freak out, this is like immediately everything close and her vision turned black; like vision going blurring, blurred vision with spots, very vague even when lying down, had this 25-30 times and 5 time so far; This spontaneous case was reported by a consumer and describes the occurrence of LOSS OF CONSCIOUSNESS (unconscious 3 times only for a second, kind of freak out, this is like immediately everything close and her vision turned black) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history provided).    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced LOSS OF CONSCIOUSNESS (unconscious 3 times only for a second, kind of freak out, this is like immediately everything close and her vision turned black) (seriousness criterion medically significant) and VISION BLURRED (like vision going blurring, blurred vision with spots, very vague even when lying down, had this 25-30 times and 5 time so far). At the time of the report, LOSS OF CONSCIOUSNESS (unconscious 3 times only for a second, kind of freak out, this is like immediately everything close and her vision turned black) and VISION BLURRED (like vision going blurring, blurred vision with spots, very vague even when lying down, had this 25-30 times and 5 time so far) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. No treatment information was provided.  Based on the current available information which includes a temporal association between the use of the product and onset of the reported events, and excluding other etiologies, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information which includes a temporal association between the use of the product and onset of the reported events, and excluding other etiologies, a causal relationship cannot be excluded.
This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. The patient's current condition, pertinent medical history and concomitant therapy were not reported. On 04-JAN-2022, the patient was vaccinated with expired dose of measles, mumps, and rubella (wistar RA 27-3) virus vaccine, live (M-M-R II) lot # S039319, expiration date: 04-DEC-2021 0.5 milliliter for prophylaxis. (dose, dose number, vaccination scheme, route of administration, and anatomical location of vaccination were not reported). No additional AE, PQC nor additional information was provided.
Received 2 injections MMR and varicella. 1 injected in each arm. I questioned why in arm as patient's extremities were very thin. Nurse said it was ok due to little needle and given SQ. 2 days later patient started with lowgrade fever and upper respiratory symptoms. Coughing. She missed school Mon & Tuesday. On Wed she went to her reg GI Dr. She had 103 fever and still coughing. Recommended back to ped. Returned to ped on Fri. Her reg Dr wasn't in. They did a CBC which was ok but low Hgb which is her norm. O2 sat was ranging from 80 - 92. They were unsure if it worked. Dr recommended going to ER. Took her to ER. She had only 1 other complaint of rt arm hurt. They did chest xray and diagnosed bronchitis. Sent home on Zithromax, prednisone & breathing treatment. Sunday morning she woke up with left cheek swollen like mumps and a red ecchymotic area under her arm by chest. While getting her ready to go to hospital she took last breath. CPR started immediately and 911 called. Breaths did not seem to be going in. EMT took over CPR. Taken to hospital where they did get a heartbeat for less than a minute.
This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient received the 2nd dose of Moderna COVID-19 vaccine from a bivalent vial instead of Monovalent) and NO ADVERSE EVENT (No adverse event) in a 64-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.     No concomitant medications were provided. The patient received first Primary monovalent dose on 26-Dec-2022 with unknown batch number. It was reported that the other pharmacist whom administered the vaccine on 27-Jan-2023, told the patient to come back in 1 month and receive the 2nd dose.  No treatment medication was provided.
Post vax, the visiting nurse reported that the patient's mother left a message reporting that her son had "chicken pox". The nurse reported that no details about the rash were given by the mother. In follow up, the patient's physician reported that the patient developed "chickenpox" in January 2001. No further information is available.
Pain and swelling at injection site and warm to touch. Left arm following PNEUMOVAX vaccination.
Patient received Covid-19 Janssen  vaccine 3/17/2021.  Patient tested positive for COVID-19 on  5/20
Patient came into pharmacy 2 weeks later complaining of sore arm and not able to lift arm.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP) from product quality group. The reporter is the patient.  A 75-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 09Sep2022 as dose 5 (booster), single (Lot number: GH9694) at the age of 75 years, in left arm for covid-19 immunization; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunization. The patient's relevant medical history included: "Vasculitis" (unspecified if ongoing), notes: Other medical history: Vasculitis; "Giant cell arteritis" (unspecified if ongoing), notes: Other medical history: Giant cell arteritis. Concomitant medication(s) included: PREDNISONE..  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Dec2022) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Rebound of mild symptoms after completing 5-day course of Paxlovid and feeling very well. Positive test. Slight body aches, cold symptoms. Low grade fever. Took treatment from 14Dec2022 to 18Dec2022. No Known allergies.
Pfizer 4/2/21, 4/30/21. Positive on 7/4/22
passed out; aching in her joints real bad; headache; Initial information received on 24-Oct-2019 regarding an unsolicited valid serious case received from a consumer/non-health care professional.  This case is linked to cases 2019SA297783 and 2019SA297782 (same reporter).  This case involves a 50 years old female patient who experienced aching in her joints real bad (arthralgia), passed out (loss of consciousness) and headache (headache), while she received vaccine YELLOW FEVER VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Notes: Patient's daughter was just diagnosed with Type 1 DM.  On an unknown date, the patient received a dose of suspect YELLOW FEVER VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site.  On an unknown date, after the vaccination the patient experienced passed out (loss of consciousness). This event was assessed as medically significant.  On an unknown date, following the vaccination the patient experienced aching in her joints real bad (arthralgia) and headache (headache).  Lab data was not reported.  Final diagnosis was joint pain, passed out and headache.  It was not reported if the patient received a corrective treatment.  The outcome of the events was unknown at the time of reporting.  Information on the batch number was requested.; Sender's Comments: This case concerns 50 years old female who had joint pain, passed out and headache following the vaccination with YELLOW FEVER VACCINE (unknown manufacturer). The time to onset is unknown. The patient's past medical history, condition at the time of vaccination, concomitant medications and lab data ruling out other etiologies would be needed for complete assessment of the case. Based upon the reported information, the role of the vaccine cannot be assessed
Redness, soreness, warm to the touch. Said had trouble sleeping on her left side where she received the immunization
Very sore arm; Fatigue for 2 days; This case was reported by a consumer via interactive digital media and described the occurrence of fatigue in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of no adverse event (received 1st dose on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced fatigue and pain in arm. On an unknown date, the outcome of the fatigue and pain in arm were recovered/resolved.   It was unknown if the reporter considered the fatigue and pain in arm to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient. The age at vaccination was not reported. The patient reported that the first dose was fine, but after 2nd dose the patient had fatigue for 2 days and a very sore arm.  The patient was good at the time of reporting and it was done. The follow-up would not possible as no contact details were available.
I received the 1st dose Moderna lot # 016B21A - no reaction  I received the 2nd dose Moderna lot #008C214 - adverse reaction - large red circle and swelling, pain in shoulder, intense itching  I received the 3rd dose Moderna lot #021C21A - adverse reaction - large red circle and swelling, pain in shoulder, intense itching  **I have taken photos to show proof
6 hours after the injection I had a very sore arm at the injection site, body and joint aches, and a slight temperature.  The next morning, 21 hours after injection, I got very lightheaded, faint, tinnitus, and nausea.  All of these side effects subsided  30 hours after injection.  The following day I had lightheadedness, tinnitus,  and nausea, which has persisted for 4 1/2 weeks.  18 hours after the injection I woke up in the night with a strange sensation of movement when I closed my eyes.  On the fifth day after injection I had am intense spell of lightheadedness, tinnitus, nausea, shaky arms and legs, and localized right side head pain, so I went to see a nurse practitioner.  All of my vital signs, blood work, and urine sample were normal.  I was advised to stay hydrated and get plenty of rest.  After 4 1/2 weeks the nausea is almost gone, however, I still have times of lightheadedness and tinnitus.  I have had some sort of "spell" on 19 of 29 days since the injection.  The side effects seem to be getting less intense and less frequent.  I have not had issues with any of this in the past.
Asthma attack and swelling in throat. Took inhaler. Symptoms subsided about 3 hours later
Vomiting, diarrhea, extreme weakness, dizziness and headache. Chills and body aches. Low grade fever 99.9. Arm pain injection site. Chest flutters and tremors. Felt like skin was on fire.
Breakthrough COVID-19; This spontaneous case was reported by a patient and describes the occurrence of BREAKTHROUGH COVID-19 (Breakthrough COVID-19) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.    Co-suspect product included non-company product NIRMATRELVIR, RITONAVIR (PAXLOVID) for an unknown indication.    No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. and NIRMATRELVIR, RITONAVIR (PAXLOVID) (unknown route) at an unspecified dose. On an unknown date, the patient experienced BREAKTHROUGH COVID-19 (Breakthrough COVID-19). At the time of the report, BREAKTHROUGH COVID-19 (Breakthrough COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Feb-2022, SARS-CoV-2 test: (Positive) Positive. On 23-Feb-2022, SARS-CoV-2 test: (Positive) Positive. On 25-Feb-2022, SARS-CoV-2 test: (Negative) Negative. On an unknown date, SARS-CoV-2 test: (Positive) Positive.         No concomitant medications was reported. Patient was a breakthrough case since had two Moderna shots and a booster. Doctor prescribed Paxlovid, and within twelve hours of the first dose, patient felt 100% better.  No treatment medications was reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Developed soreness and mild swelling at injection site 8 hrs later. Then 19 hrs later, developed mild to moderate chills.
pt recvd vax 5FEB96 & 12FEB pt began sl fever;13FEB PM fever was 104.7;sx activity began;EMS called pt taken to hosp;discharged same evening;15FEb pt t102, but improving;MD states pt is having response to vax
Narrative: COVID infection following COVID vaccine series 01/20, Pfizer, dose #1 02/17, Pfizer, dose #2 08/16 pt cc: headache, fatigue, exposure: unknown 08/19 COVID swab, result: detected 08/19 SARS-COV-2 Variant Sequencing result: pending
Seven days after the immunization the child developed a fever of 104 deg. F. for 2 days. Parent took the child to the ER.
Started with diarrhea, nausea, severe fatigue & headache on 4/26/21.  On 4/27 & 4/28/21, severe pain in back and radiating down legs. Increased numbness in hands & legs, legs heavy and hard to walk, severe headache.  Pain unrelenting despite percocet , tylenol & compazine.   I had stopped my SQ immune globulin (SCIG) infusions a week prior and a week after the vaccine - as recommended by my neurologist.  I was in this second week when these symptoms exacerbated.  It was very similar to a CIDP relapse.
pregnancy test on 31Jan and was positive; pain in every joint; increasing pain all over body; Elevated liver enzymes; low WBC; UTI symptoms; blood in urine; not felt well; This is a spontaneous report from a contactable nurse (patient). A 28-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) (at 28 years of age), dose 1 intramuscular, administered in arm left on 19Jan2021 18:00 (Batch/Lot Number: EL3248) as a single dose for COVID-19 immunisation. Medical history included sulfa allergy. Concomitant medication included vitamin d3 (VITAMIN D3), vitamin b complex (VITAMIN B COMPLEX) and prenatal vitamins which the patient received with 2 weeks of vaccination. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination.  The patient was pregnant. It was reported that after receiving vaccine, the patient had not felt well on 20Jan2021. She went into urgent care on Saturday 23Jan2021 for UTI symptoms. She had blood in urine, went to primary care appointment on 27Jan2021 had more blood in urine per urinalysis. She went into the emergency room for increasing pain all over body. CT scan was done, lab work done (both unknown results). She had elevated liver enzymes, low WBC, blood in urine on 28Jan2021. She had extreme pain all over body, pain in every joint on 29Jan2021, was essentially bed bound through 31Jan2021. She took at home pregnancy test on 31Jan2021 and was positive. She was also prescribed MACROBID for UTI from the urgent care, completed the course per primary physician- even though no UTI was determined- just blood in urine. The patient underwent lab tests and procedures which included urine analysis: blood in urine on 23Jan2021, more blood in urine on 27Jan2021 and blood in urine on 28Jan2021; hepatic enzyme increased on 28Jan2021; and white blood cell count: low on 28Jan2021. Therapeutic measures were taken as a result of uti symptoms (urinary tract infection). She was tested for SARS-CoV-1 test through nasal swab on 29Jan2021 with negative result. The events resulted to doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. Therapeutic measure was taken as a result of UTI and no treatment received from other events. The events are reported non-serious. The outcome of not felt well was recovering while unknown for other events.
Low estrogen; can't concentrate; can't focus; can't sleep; depressed; has anxiety; This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP). Other Case identifier(s): MOD21-160615 (Moderna), MOD21-160642 (Moderna).  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: BLOOD OESTROGEN DECREASED (non-serious), outcome "unknown", described as "Low estrogen"; DISTURBANCE IN ATTENTION (non-serious), outcome "unknown", described as "can't concentrate"; VISION BLURRED (non-serious), outcome "unknown", described as "can't focus"; INSOMNIA (non-serious), outcome "unknown", described as "can't sleep"; DEPRESSED MOOD (non-serious), outcome "unknown", described as "depressed"; ANXIETY (non-serious), outcome "unknown", described as "has anxiety". Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER_INC-202101533632
STARTING AROUND 12:00pPM I EXPERIANCED TWO TIMES WHERE MY HEART STARTED TO RACE FOR ROUGHLY 5 SECONDS.  AFTERWARDS I EXPERIANCED SHOCK LIKE SENSATIONS AROUND CHEST, AND BACK. NOT SURE IF RELATED TO THE INJECTION BUT NEVER HAD PRIOR AND DIDN'T HAVE THE DAY AFTER OF SINCE
EMPLOYEE STATED THAT HER EYES STARTED TO DRY UP AND SHE DIDN'T NOTICE TILL SHE GOT HOME THAT SHE HAD HIVES ON HER LEGS AND BACK. DONOR PUT BENADRYL CREME ON EFFECTED AREAS.
Shoulder arm injury. ICU admission. Surgery I&D. Immune system problems. Multiple infections.